Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray International Regulatory News (MYI)

Share Price Information for Murray International (MYI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.00
Bid: 249.00
Ask: 250.00
Change: 1.00 (0.40%)
Spread: 1.00 (0.402%)
Open: 247.50
High: 249.50
Low: 247.50
Prev. Close: 248.00
MYI Live PriceLast checked at -
Murray International is an Investment Trust

To achieve an above average dividend yield, with long term growth in dividends and capital ahead of inflation, by investing principally in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues update on Murray International Trust (MYI): Attractive offering of income and capital growth

18 Jan 2024 09:32

Edison Investment Research Limited Edison issues update on Murray International Trust (MYI): Attractive offering of income and capital growth 18-Jan-2024 / 09:31 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 18 January 2024

 

Edison issues update on Murray International Trust (MYI): Attractive offering of income and capital growth

Murray International Trust’s (MYI’s) three managers, Bruce Stout, Martin Connaghan and Samantha Fitzpatrick, have worked closely together since 2001, so it will be business as usual when Stout retires at the end of June. The trust has amassed considerable revenue reserves (equivalent to around one year’s annual dividend) so was able to continue its progressive dividend policy during COVID; MYI returned to a covered dividend in FY22. Despite high inflation preventing real (above inflation) dividend growth in recent years, the trust now has an 18-year record of consecutive annual dividend growth and offers an attractive 4.6% dividend yield, which compares favourably with its peers in the AIC Global Equity Income sector, most of which, unlike MYI, can pay dividends out of capital.

Portfolio turnover is relatively low as Stout, Connaghan and Fitzpatrick invest with a long-term perspective, seeking ‘good businesses at good prices’. Decision-making is a collaborative, measured process, and all three managers must agree on a transaction before it goes ahead. Recent new positions include alcoholic beverage companies Diageo and Pernod Ricard, where share price weakness provided attractive entry points.

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors – Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1818003 18-Jan-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:03 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:42 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20231:00 pmRNSNet Asset Value(s)
31st Jan 202312:33 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:31 pmRNSNet Asset Value(s)
24th Jan 202312:58 pmRNSNet Asset Value(s)
24th Jan 202310:06 amRNSDirector/PDMR Shareholding
23rd Jan 20234:22 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 20234:00 pmRNSCompliance with Market Abuse Regulation
18th Jan 202310:50 amRNSPortfolio disclosure
17th Jan 202312:18 pmRNSNet Asset Value(s)
17th Jan 202311:21 amRNSBlock listing Interim Review
16th Jan 20234:23 pmRNSDirector/PDMR Shareholding
16th Jan 20232:11 pmRNSGearing disclosure
16th Jan 20231:05 pmRNSNet Asset Value(s)
13th Jan 20231:08 pmRNSNet Asset Value(s)
12th Jan 202312:05 pmRNSNet Asset Value(s)
11th Jan 202311:09 amRNSNet Asset Value(s)
10th Jan 202312:01 pmRNSNet Asset Value(s)
9th Jan 20235:18 pmRNSGearing disclosure
9th Jan 202312:12 pmRNSNet Asset Value(s)
6th Jan 20233:03 pmRNSMonth End Net Asset Value(s)
6th Jan 202312:52 pmRNSNet Asset Value(s)
5th Jan 202312:11 pmRNSNet Asset Value(s)
4th Jan 20235:05 pmRNSQuarterly disclosure
4th Jan 202312:22 pmRNSNet Asset Value(s)
3rd Jan 20232:50 pmRNSGearing disclosure
30th Dec 202211:53 amRNSNet Asset Value(s)
29th Dec 20221:08 pmRNSNet Asset Value(s)
29th Dec 202212:56 pmRNSGearing disclosure
28th Dec 202211:35 amRNSNet Asset Value(s)
23rd Dec 202212:18 pmRNSNet Asset Value(s)
22nd Dec 202211:19 amRNSNet Asset Value(s)
21st Dec 20222:58 pmRNSNet Asset Value(s)
20th Dec 202211:38 amRNSNet Asset Value(s)
19th Dec 20223:49 pmRNSGearing disclosure
19th Dec 202212:50 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.